Early treatment of minocycline alleviates white matter and cognitive impairments after chronic cerebral hypoperfusion

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Ma, Jing ^a,c   Zhang, Jing ^a,d   Hou, Wei Wei ^a   Wu, Xiao Hua ^a   Liao, Ru Jia ^a   Chen, Ying ^a   Wang, Zhe ^a   Zhang, Xiang Nan ^a,b   Zhang, Li San ^a   Zhou, Yu Dong ^a   Chen, Zhong ^a,b   Hu, Wei Wei ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ISOMERASE; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; MIF PROTEIN, MOUSE; MINOCYCLINE; NEUROPROTECTIVE AGENT;

ANIMAL; C57BL MOUSE; CAROTID ARTERY INJURY; CELL CULTURE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; COGNITION DISORDERS; COMPLICATION; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; ELECTRON MICROSCOPY; MALE; MAZE TEST; METABOLISM; MICROGLIA; MOUSE; MULTIINFARCT DEMENTIA; OLIGODENDROGLIA; PATHOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; STEM CELL; WHITE MATTER;

ANIMALS; CAROTID ARTERY INJURIES; CELL PROLIFERATION; CELLS, CULTURED; COGNITION DISORDERS; DEMENTIA, VASCULAR; DISEASE MODELS, ANIMAL; G2 PHASE; INTRAMOLECULAR OXIDOREDUCTASES; LIPOPOLYSACCHARIDES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICROGLIA; MICROSCOPY, ELECTRON; MINOCYCLINE; NEUROPROTECTIVE AGENTS; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; S PHASE; STEM CELLS; WHITE MATTER;

EID: 84945305624     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12079     Document Type: Article

References (51)

1. Kalaria, R. N. et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 7, 812 (2008).
2. Selnes, O. A. & Vinters, H. V. Vascular cognitive impairment. Nat. Clin. Pract. Neurol. 2, 538 (2006).
3. Baskys, A. & Cheng, J. X. Pharmacological prevention and treatment of vascular dementia: approaches and perspectives. Exp. Gerontol. 47, 887 (2012).
4. Craig, D. & Birks, J. Galantamine for vascular cognitive impairment. Cochrane. Database. Syst. Rev. D4746 (2006).
5. Roman, G. C. et al. Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size. Stroke 41, 1213 (2010).
6. Aronson, A. L. Pharmacotherapeutics of the newer tetracyclines. J. Am. Vet. Med. Assoc. 176, 1061 (1980).
7. Good, M. L. & Hussey, D. L. Minocycline: stain devil? Br. J. Dermatol. 149, 237 (2003).
8. Gough, A., Chapman, S., Wagstaff, K., Emery, P. & Elias, E. Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ 312, 169 (1996).
9. Garrido-Mesa, N., Zarzuelo, A. & Galvez, J. Minocycline: far beyond an antibiotic. Br. J. Pharmacol. 169, 337 (2013).
10. Liebigt, S. et al. Effects of rehabilitative training and anti-inflammatory treatment on functional recovery and cellular reorganization following stroke. Exp. Neurol. 233, 776 (2012).
11. Darman, J. et al. Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. J. Neurosci. 24, 7566 (2004).
12. Noble, W. et al. Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease. Faseb. J. 23, 739 (2009).
13. Metz, L. M. et al. Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann. Neurol. 55, 756 (2004).
14. Choi, Y. et al. Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharmacol. 32, 2393 (2007).
15. Zhao, F., Hua, Y., He, Y., Keep, R. F. & Xi, G. Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage. Stroke 42, 3587 (2011).
16. Fan, L. W., Lin, S., Pang, Y., Rhodes, P. G. & Cai, Z. Minocycline attenuates hypoxia-ischemia-induced neurological dysfunction and brain injury in the juvenile rat. Eur. J. Neurosci. 24, 341 (2006).
17. Cai, Z., Lin, S., Fan, L. W., Pang, Y. & Rhodes, P. G. Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience 137, 425 (2006).
18. Cho, K. O., La HO, Cho, Y. J., Sung, K. W. & Kim, S. Y. Minocycline attenuates white matter damage in a rat model of chronic cerebral hypoperfusion. J. Neurosci. Res. 83, 285 (2006).
19. Tsuji, M., Wilson, M. A., Lange, M. S. & Johnston, M. V. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp. Neurol. 189, 58 (2004).
20. Li, W. W., Setzu, A., Zhao, C. & Franklin, R. J. Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J. Neuroimmunol. 158, 58 (2005).
21. Roman, G. C., Erkinjuntti, T., Wallin, A., Pantoni, L. & Chui, H. C. Subcortical ischaemic vascular dementia. Lancet Neurol. 1, 426 (2002).
22. Shibata, M., Ohtani, R., Ihara, M. & Tomimoto, H. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 35, 2598 (2004).
23. Ma, J. et al. Protective effect of carnosine on subcortical ischemic vascular dementia in mice. CNS Neurosci. Ther. 18, 745 (2012).
24. Yoshizaki, K. et al. Chronic cerebral hypoperfusion induced by right unilateral common carotid artery occlusion causes delayed white matter lesions and cognitive impairment in adult mice. Exp. Neurol. 210, 585 (2008).
25. Sarti, C., Pantoni, L., Bartolini, L. & Inzitari, D. Persistent impairment of gait performances and working memory after bilateral common carotid artery occlusion in the adult Wistar rat. Behav. Brain Res. 136, 13 (2002).
26. Morris, R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47 (1984).
27. Back, S. A. Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechanisms. Ment. Retard. Dev. Disabil. Res. Rev. 12, 129 (2006).
28. Baumann, N. & Pham-Dinh, D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 81, 871 (2001).
29. Chomiak, T. & Hu, B. What is the optimal value of the g-ratio for myelinated fibers in the rat CNS? A theoretical approach. PLoS One 4, e7754 (2009).
30. Hayakawa, K. et al. Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism. Stroke 39, 951 (2008).
31. Bhasin, M., Wu, M. & Tsirka, S. E. Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis. BMC Immunol. 8, 10 (2007).
32. Aguirre, A., Dupree, J. L., Mangin, J. M. & Gallo, V. A functional role for EGFR signaling in myelination and remyelination. Nat. Neurosci. 10, 990 (2007).
33. Etxeberria, A., Mangin, J. M., Aguirre, A. & Gallo, V. Adult-born SVZ progenitors receive transient synapses during remyelination in corpus callosum. Nat. Neurosci. 13, 287 (2010).
34. Schmitz, T., Endesfelder, S., Chew, L. J., Zaak, I. & Buhrer, C. Minocycline protects oligodendroglial precursor cells against injury caused by oxygen-glucose deprivation. J. Neurosci. Res. 90, 933 (2012).
35. Tanaka, T., Murakami, K., Bando, Y. & Yoshida, S. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination. J. Neurochem. 127, 259 (2013).
36. Cai, Z. Y., Yan, Y. & Chen, R. Minocycline reduces astrocytic reactivation and neuroinflammation in the hippocampus of a vascular cognitive impairment rat model. Neurosci. Bull. 26, 28 (2010).
37. Cai, Z. Y. et al. Minocycline attenuates cognitive impairment and restrains oxidative stress in the hippocampus of rats with chronic cerebral hypoperfusion. Neurosci. Bull. 24, 305 (2008).
38. Fox, C. et al. Minocycline confers early but transient protection in the immature brain following focal cerebral ischemiareperfusion. J. Cereb. Blood Flow Metab. 25, 1138 (2005).
39. Selnes, O. A. & Vinters, H. V. Vascular cognitive impairment. Nat. Clin. Pract. Neurol. 2, 538 (2006).
40. Sharp, S. I., Aarsland, D., Day, S., Sonnesyn, H. & Ballard, C. Hypertension is a potential risk factor for vascular dementia: systematic review. Int. J. Geriatr. Psychiatry 26, 661 (2011).
41. Ihara, M. et al. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodies. Acta Neuropathol. 119, 579 (2010).
42. Benarroch, E. E. Oligodendrocytes: Susceptibility to injury and involvement in neurologic disease. Neurology 72, 1779 (2009).
43. Schmitz, T. et al. Cellular changes underlying hyperoxia-induced delay of white matter development. J. Neurosci. 31, 4327 (2011).
44. Arnett, H. A. et al. TNF Alpha Promotes Proliferation of Oligodendrocyte Progenitors and Remyelination. Nat. Neurosci. 4, 1116 (2001).
45. Gootjes, L. et al. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. Dement. Geriatr. Cogn. Disord 18, 180 (2004).
46. Liebetanz, D. & Merkler, D. Effects of Commissural De-and Remyelination On Motor Skill Behaviour in the Cuprizone Mouse Model of Multiple Sclerosis. Exp. Neurosci. 202, 217 (2006).
47. Garrido-Mesa, N., Zarzuelo, A. & Galvez, J. What is Behind the Non-Antibiotic Properties of Minocycline? Pharmacol. Res. 67, 18 (2013).
48. Schmitz, T. et al. Minocycline Protects the Immature White Matter Against Hyperoxia. Exp. Neurol. 254, 153 (2014).
49. Hu, W. W. et al. Chronic h1-antihistamine treatment increases seizure susceptibility after withdrawal by impairing glutamine synthetase. CNS Neurosci. Ther. 18, 683 (2012).
50. Hayakawa, K. et al. Vascular endothelial growth factor regulates the migration of oligodendrocyte precursor cells. J. Neurosci. 31, 10666 (2011).
51. Wang, R. et al. Oxygen-glucose deprivation induced glial scar-like change in astrocytes. PLoS One 7, e37574 (2012).